PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026Revue Médicale Suisse0 citations

Médecine de l’adolescence : ce qui a changé en 2025

View Full Paper
PSPatrick André SchmittRVRachel Rutz VoumardAZAdèle Zufferey

Key Points

  • To clarify the medical treatment framework for transgender and non-binary adolescents experiencing gender dysphoria.
  • Published by the National Advisory Commission on Biomedical Ethics
  • Conducted a review of scientific evidence
  • Focused on ethical considerations and societal implications
  • Established a framework for individualized treatment
  • Emphasized the importance of recognizing adolescent autonomy
  • Highlighted the need for interdisciplinary collaboration in treatment

Abstract

The health of transgender and non-binary adolescents has emerged as a major topic at the intersection of medicine, ethics, and societal issues. At the request of several cantonal medical officers, the National Advisory Commission on Biomedical Ethics published an opinion paper on the medical treatment of minors experiencing gender dysphoria at the end of 2024. The document provides a clear framework, based on scientific evidence and biomedical ethics, in a context of uncertainty and sociopolitical polarization. It emphasizes an individualized and careful evaluation of benefits and risks, the recognition of adolescents' evolving autonomy, interdisciplinary collaboration, and the protection of each adolescent's right to an open future.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schmitt et al. (2026) studied this question.

synapsesocial.com/papers/69746126bb9d90c67120b050https://doi.org/10.53738/revmed.2026.22.946.48207
Ask AI
Helpful
Bookmark
Share
View Full Paper